168 related articles for article (PubMed ID: 14739492)
21. The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas.
Aylwin SJ; Welch JP; Davey CL; Geddes JF; Wood DF; Besser GM; Grossman AB; Monson JP; Burrin JM
J Clin Endocrinol Metab; 2001 Jun; 86(6):2476-83. PubMed ID: 11397843
[TBL] [Abstract][Full Text] [Related]
22. Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification.
Dottermusch M; Schüller U; Hagel C; Saeger W
Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12870. PubMed ID: 36527335
[TBL] [Abstract][Full Text] [Related]
23. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
[TBL] [Abstract][Full Text] [Related]
24. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
[TBL] [Abstract][Full Text] [Related]
25. Pituitary adenomas that produce adrenocorticotropic hormone and alpha-subunit: clinicopathological, immunohistochemical, ultrastructural, and immunoelectron microscopic studies in nine cases.
Berg KK; Scheithauer BW; Felix I; Kovacs K; Horvath E; Klee GG; Laws ER
Neurosurgery; 1990 Mar; 26(3):397-403. PubMed ID: 1690866
[TBL] [Abstract][Full Text] [Related]
26. Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion.
Skelly RH; Korbonits M; Grossman A; Besser GM; Monson JP; Geddes JF; Burrin JM
J Clin Endocrinol Metab; 2000 Jul; 85(7):2537-42. PubMed ID: 10902805
[TBL] [Abstract][Full Text] [Related]
27. Contribution of immunohistochemistry, electron microscopy, and cell culture to the characterization of nonfunctioning pituitary adenomas: a study of 40 cases.
Croue A; Beldent V; Rousselet MC; Guy G; Rohmer V; Bigorgne JC; Saint-Andre JP
Hum Pathol; 1992 Dec; 23(12):1332-9. PubMed ID: 1468769
[TBL] [Abstract][Full Text] [Related]
28. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.
Kim K; Arai K; Sanno N; Osamura RY; Teramoto A; Shibasaki T
Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110
[TBL] [Abstract][Full Text] [Related]
29. [Gonadotroph pituitary adenomas].
Chanson P
Ann Endocrinol (Paris); 2000 Sep; 61(3):258-68. PubMed ID: 10970952
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical and ultrastructural study of clinically nonfunctioning pituitary adenomas.
Zhao D; Tomono Y; Tsuboi K; Nose T
Neurol Med Chir (Tokyo); 2000 Sep; 40(9):453-6; discussion 456-7. PubMed ID: 11021076
[TBL] [Abstract][Full Text] [Related]
31. Application of catalyzed signal amplification in immunodetection of gonadotropin subunits in clinically nonfunctioning pituitary adenomas.
Sanno N; Teramoto A; Sugiyama M; Itoh Y; Osamura RY
Am J Clin Pathol; 1996 Jul; 106(1):16-21. PubMed ID: 8701926
[TBL] [Abstract][Full Text] [Related]
32. Galanin in human pituitary adenomas: frequency and clinical significance.
Leung B; Iisma TP; Leung KC; Hort YJ; Turner J; Sheehy JP; Ho KK
Clin Endocrinol (Oxf); 2002 Mar; 56(3):397-403. PubMed ID: 11940053
[TBL] [Abstract][Full Text] [Related]
33. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.
Hsu DW; Hooi SC; Hedley-Whyte ET; Strauss RM; Kaplan LM
Am J Pathol; 1991 Apr; 138(4):897-909. PubMed ID: 1707237
[TBL] [Abstract][Full Text] [Related]
34. Gonadotroph cell adenomas of the pituitary.
Snyder PJ
Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559
[TBL] [Abstract][Full Text] [Related]
35. Histologic and immunohistochemical study of clinically non-functioning pituitary adenomas: special reference to gonadotropin-positive adenomas.
Sano T; Yamada S
Pathol Int; 1994 Sep; 44(9):697-703. PubMed ID: 7804432
[TBL] [Abstract][Full Text] [Related]
36. [Immunohistochemical and electron microscopic study of nonfunctioning pituitary adenomas. With special reference to gonadotroph adenomas].
Miyazaki H; Toya S; Otani M; Wada C; Kameya T
Neurol Med Chir (Tokyo); 1988 May; 28(5):442-7. PubMed ID: 2471096
[No Abstract] [Full Text] [Related]
37. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
38. Cushing's disease due to female gonadotroph adenoma of the pituitary.
Ikeda H; Yoshimoto T; Kovacs K; Horvath E
Clin Endocrinol (Oxf); 1995 Sep; 43(3):383-6. PubMed ID: 7586610
[TBL] [Abstract][Full Text] [Related]
39. Ultrastructural markers in the pathologic diagnosis of pituitary adenomas.
Horvath E
Ultrastruct Pathol; 1994; 18(1-2):171-9. PubMed ID: 8191623
[TBL] [Abstract][Full Text] [Related]
40. Gene expression study of thyrotropin releasing hormone (TRH) receptor using RT-PCR: relationship to clinical and immunohistochemical phenotypes in a series of human pituitary adenomas.
Igarashi-Migitaka J; Yamada S; Hara M; Sano T; Ozawa Y; Ohtani-Kaneko R; Hirata K
Endocr J; 2003 Aug; 50(4):459-67. PubMed ID: 14599121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
